Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer.

Yeyeodu ST, Kidd LR, Kimbro KS.

Cancer Immunol Res. 2019 Sep;7(9):1384-1389. doi: 10.1158/2326-6066.CIR-18-0564.

PMID:
31481520
2.

Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion.

Martin ME, Reaves DK, Jeffcoat B, Enders JR, Costantini LM, Yeyeodu ST, Botta D, Kavanagh TJ, Fleming JM.

Nanomedicine. 2019 Jul 24;21:102070. doi: 10.1016/j.nano.2019.102070. [Epub ahead of print]

PMID:
31351238
3.

In Situ Drug Delivery to Breast Cancer-Associated Extracellular Matrix.

Fleming JM, Yeyeodu ST, McLaughlin A, Schuman D, Taylor DK.

ACS Chem Biol. 2018 Oct 19;13(10):2825-2840. doi: 10.1021/acschembio.8b00396. Epub 2018 Sep 18. Review.

PMID:
30183254
4.

Pregnane X Receptor-Humanized Mice Recapitulate Gender Differences in Ethanol Metabolism but Not Hepatotoxicity.

Spruiell K, Gyamfi AA, Yeyeodu ST, Richardson RM, Gonzalez FJ, Gyamfi MA.

J Pharmacol Exp Ther. 2015 Sep;354(3):459-70. doi: 10.1124/jpet.115.224295. Epub 2015 Jul 9.

5.

IRAK4 and TLR3 Sequence Variants may Alter Breast Cancer Risk among African-American Women.

Yeyeodu ST, Kidd LR, Oprea-Ilies GM, Burns BG, Vancleave TT, Shim JY, Kimbro KS.

Front Immunol. 2013 Oct 29;4:338. doi: 10.3389/fimmu.2013.00338. eCollection 2013.

6.

Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment.

Kidd LC, Rogers EN, Yeyeodu ST, Jones DZ, Kimbro KS.

Breast Cancer (Dove Med Press). 2013 Jun 28;5:43-51. doi: 10.2147/BCTT.S29172. eCollection 2013. Review.

7.

A rapid, inexpensive high throughput screen method for neurite outgrowth.

Yeyeodu ST, Witherspoon SM, Gilyazova N, Ibeanu GC.

Curr Chem Genomics. 2010 Dec 13;4:74-83. doi: 10.2174/1875397301004010074.

Supplemental Content

Loading ...
Support Center